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In a previous publication (1), we evaluated the Genotype MTBDR (GT-MTBDR; Hain Lifescience, Nehren, Germany) assay as a rapid diagnostic tool for multidrug resistance (MDR) detection in Mycobacterium tuberculosis isolates and clinical specimens. The main limitation of the test was the low sensitivity for isoniazid resistance detection (70%), due to the targeting of only one (katG) of the genes involved (2) . Furthermore, the test performance on clinical specimens was suboptimal because of the lack of a clear hybridization signal (unpublished data).
Recently, a new version of the test, the Genotype MTBDRplus (GT-MTBDRplus) assay, has been developed in order to improve the assay's sensitivity for isoniazid resistance and direct detection of drug resistance in clinical specimens. It targets all the genes included in the previous test with the addition of codons 505 to 510 in the hot-spot region of rpoB, to improve the detection of rifampin resistance, and the promoter region of the inhA gene (nucleotides Ϫ8, Ϫ15, and Ϫ16) for isoniazid resistance.
We tested with the GT-MTBDRplus assay 173 isoniazidresistant isolates (Table 1 ) and 78 clinical specimens ( Fig. 1 ) that had been previously analyzed with the GT-MTBDR version and compared the results with those of sequence analysis. DNA extraction from isolates and clinical specimens was performed as previously described (1) .
The use of the GT-MTBDRplus assay allowed the correct identification of an additional 11.6% (20/173) of isoniazidresistant strains compared to the results with the GT-MTBDR, with a specificity of 100%. In one sample, none of the tests allowed the detection of the katG gene due to the presence of several mutations in the same gene, as confirmed by the sequence analysis. Both the assays were interpreted as indeterminate for the katG analysis.
The two tests were also evaluated side by side ( Fig. 1) Results for all of the four samples showing simultaneously mutated and wild-type patterns with the first version of the assay were confirmed by the GT-MTBDRplus assay (Fig. 1) . a The isolates tested (n ϭ 173) were previously determined to be isoniazid resistant by drug susceptibility testing.
b The GT-MTBDR assay did not target the inhA gene. c In one isolate, the katG gene was not detected by either the GT-MTBDR or GT-MTBDRplus assay, which sequence analysis confirmed as being due to several mutations in the same gene.
The increased sensitivity of GT-MTBDRplus is due to the introduction of new targeted genes for isoniazid resistance coupled with better primer and probe design, allowing improved sensitivity with direct clinical specimens to provide rapid direct detection of drug resistance, essential to improve case management and, consequently, tuberculosis control.
